HEALTHCARE
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
A view of the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom...
HEALTHCARE
23andMe files for bankruptcy, Anne Wojcicki steps down as CEO
Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday,...
HEALTHCARE
Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty...
HEALTHCARE
Pope Francis to be released from the hospital
A rose and and an image of Pope Francis are placed at the statue of late Pope John Paul II outside Gemelli Hospital,...
HEALTHCARE
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound and its diabetes...
HEALTHCARE
AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe
AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British...
HEALTHCARE
2 portfolio stocks that should benefit from a boost in spending by older Americans
Home Depot and GE Healthcare are companies Mizuho believes will get a boost from an aging American population.Source link
Subscribe
– Stay updated in real-time
– Get in-depth insights and trends
– News straight to your inbox
Must read